SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-099551
Filing Date
2020-04-06
Accepted
2020-04-06 16:35:59
Documents
11
Period of Report
2020-04-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d777789d8k.htm 8-K 29344
2 EX-99.1 d777789dex991.htm EX-99.1 16200
3 GRAPHIC g777789ex99_1s1g1.jpg GRAPHIC 313148
4 GRAPHIC g777789ex99_1s2g1.jpg GRAPHIC 734929
5 GRAPHIC g777789ex99_1s3g1.jpg GRAPHIC 279123
6 GRAPHIC g777789ex99_1s4g1.jpg GRAPHIC 296397
7 GRAPHIC g777789ex99_1s5g1.jpg GRAPHIC 292935
8 GRAPHIC g777789ex99_1s6g1.jpg GRAPHIC 301671
9 GRAPHIC g777789ex99_1s7g1.jpg GRAPHIC 315205
10 GRAPHIC g777789ex99_1s8g1.jpg GRAPHIC 299179
11 GRAPHIC g777789ex99_1s9g1.jpg GRAPHIC 290802
  Complete submission text file 0001193125-20-099551.txt   4350160
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 20777358
SIC: 2834 Pharmaceutical Preparations